Total Payments
$310.50
2023 Payments
$50.12
Companies
7
Transactions
13
Medicare Patients
20,408
Medicare Billing
$614,022
Payment Breakdown by Category
Food & Beverage$310.50 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $310.50 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ATRICURE, INC. | $138.66 | 2 | $0 (2020) |
| Eisai Inc. | $91.08 | 6 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $20.92 | 1 | $0 (2023) |
| Lundbeck LLC | $18.42 | 1 | $0 (2022) |
| Biogen, Inc. | $15.09 | 1 | $0 (2023) |
| SK Life Science, Inc. | $14.11 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $12.22 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $50.12 | 3 | Ferring Pharmaceuticals Inc. ($20.92) |
| 2022 | $18.42 | 1 | Lundbeck LLC ($18.42) |
| 2021 | $85.76 | 6 | Eisai Inc. ($73.54) |
| 2020 | $138.66 | 2 | ATRICURE, INC. ($138.66) |
| 2019 | $17.54 | 1 | EISAI INC. ($17.54) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2023 | Ferring Pharmaceuticals Inc. | CIMZIA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2023 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Neurology | ||||||
| 05/20/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.11 | General |
| 09/15/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: NEUROLOGY | ||||||
| 10/28/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Neurology | ||||||
| 09/20/2021 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $12.22 | General |
| 08/31/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $11.56 | General |
| Category: Neurology | ||||||
| 06/16/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $12.06 | General |
| Category: Neurology | ||||||
| 05/06/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: Neurology | ||||||
| 04/20/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Neurology | ||||||
| 01/26/2020 | ATRICURE, INC. | ATRICURE ATRICLIP LAA EXCLUSION (Device), ATRICURE SYNERGY ABLATION SYSTEM | Food and Beverage | Cash or cash equivalent | $111.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/26/2020 | ATRICURE, INC. | ATRICURE SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $27.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2019 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $17.54 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 69 | 4,573 | 4,700 | $548,431 | $134,455 |
| 2022 | 68 | 5,449 | 5,613 | $665,318 | $163,661 |
| 2021 | 71 | 5,609 | 5,764 | $663,639 | $175,854 |
| 2020 | 69 | 4,777 | 4,934 | $512,903 | $140,053 |
Total Patients
20,408
Total Services
21,011
Medicare Billing
$614,022
Procedure Codes
310
All Medicare Procedures & Services
310 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 70553 | Mri scan of brain before and after contrast | Facility | 2023 | 197 | 198 | $65,868 | $16,373 | 24.9% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 410 | 418 | $51,700 | $12,417 | 24.0% |
| 72148 | Mri scan of lower spinal canal without contrast | Facility | 2023 | 200 | 200 | $43,419 | $10,897 | 25.1% |
| 70551 | Mri scan of brain without contrast | Facility | 2023 | 144 | 146 | $31,190 | $7,979 | 25.6% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 79 | 80 | $27,490 | $7,164 | 26.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 118 | 118 | $27,140 | $6,488 | 23.9% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 148 | 149 | $23,129 | $5,357 | 23.2% |
| 72141 | Mri scan of upper spinal canal without contrast | Facility | 2023 | 85 | 86 | $18,580 | $4,721 | 25.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 65 | 65 | $16,744 | $4,278 | 25.5% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 535 | 576 | $15,630 | $3,840 | 24.6% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 60 | 60 | $15,548 | $3,621 | 23.3% |
| 70496 | Ct scan of blood vessels of head with contrast | Facility | 2023 | 57 | 57 | $14,645 | $3,481 | 23.8% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 49 | 50 | $13,316 | $3,312 | 24.9% |
| 70498 | Ct scan of blood vessels of neck with contrast | Facility | 2023 | 55 | 55 | $14,086 | $3,233 | 23.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 109 | 112 | $11,963 | $2,919 | 24.4% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 312 | 318 | $10,228 | $2,422 | 23.7% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Facility | 2023 | 30 | 30 | $9,903 | $2,421 | 24.5% |
| 70486 | Ct scan of face without contrast | Facility | 2023 | 70 | 70 | $8,728 | $2,147 | 24.6% |
| 70544 | Mri scan of blood vessels of head without contrast | Facility | 2023 | 48 | 48 | $8,397 | $2,111 | 25.1% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2023 | 51 | 55 | $6,710 | $1,680 | 25.0% |
| 72131 | Ct scan of lower spine without contrast | Facility | 2023 | 33 | 33 | $4,955 | $1,111 | 22.4% |
| 72146 | Mri scan of middle spinal canal without contrast | Facility | 2023 | 19 | 19 | $4,102 | $1,052 | 25.6% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 27 | 27 | $3,990 | $1,045 | 26.2% |
| 76705 | Limited ultrasound scan of abdomen | Facility | 2023 | 48 | 48 | $4,100 | $1,023 | 25.0% |
| 78072 | Nuclear medicine study of parathyroid with spect and ct scan | Facility | 2023 | 16 | 16 | $3,395 | $924.32 | 27.2% |
About Dr. Yogesh Patel, MD
Dr. Yogesh Patel, MD is a Diagnostic Radiology healthcare provider based in Toldeo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861584021.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yogesh Patel, MD has received a total of $310.50 in payments from pharmaceutical and medical device companies, with $50.12 received in 2023. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($310.50).
As a Medicare-enrolled provider, Patel has provided services to 20,408 Medicare beneficiaries, totaling 21,011 services with total Medicare billing of $614,022. Data is available for 4 years (2020–2023), covering 310 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Toldeo, OH
- Active Since 09/28/2006
- Last Updated 08/13/2020
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1861584021
Products in Payments
- ATRICURE ATRICLIP LAA EXCLUSION (Device) $111.31
- Dayvigo (Drug) $73.54
- ATRICURE SYNERGY ABLATION SYSTEM (Device) $27.35
- CIMZIA (Drug) $20.92
- VYEPTI (Biological) $18.42
- Fycompa (Drug) $17.54
- SPINRAZA (Biological) $15.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.